AMPK Activator - mTOR Inhibitor - Autophagy inducer

Metformin activates adenosine monophosphate-activated protein kinase (AMPK), an enzyme that coordinates control of cell growth and autophagy. Metformin can be used to induce autophagy in an AMPK-dependent manner.

Metformin is used as an antidiabetic drug and displays significant growth inhibitory effects in several cancer models [1]. Experimental data indicate that metformin blocks lymphoma cell growth through the inhibition of the mTOR pathway and the induction of autophagy [2].


Synonym: Metformin hydrochloride
CAS number: 1115-70-4
Formula: C4H11N5, HCL
Molecular weight: 165.6
Solubility: 100 mM in water
Purity: >98%
Working concentration: 2 - 10 mM


- 1 g Metformin

Metformin is provided as a solid and shipped at room temperature. Store at 4°C.
Solid product is stable 2 years when properly stored.


1. Dowling R. et al., 2011. Understanding the benefit of metformin use in cancer treatment. BMC Medicine 9:33.
2. Shi W. et al., 2012. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis. 3:e275.



Description AMPK activator - Autophagy inducer
Cat. Codetlrl-metf
Unit Size1 g
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "".